WWW.WSJ.COM
Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion
The deal allows the pharmaceutical company to bring in house its current partner with the aim of developing cell therapies in oncology, immunology and neurology.
0 Commenti 0 condivisioni 18 Views